WC
Winters Chad
Chief Financial Officer
OtherM
Insider track record
CFONot enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Winters Chad, Chief Financial Officer. Director active across 2 companies, notably WEST PHARMACEUTICAL SERVICES INC. In total, 17 reports have been recorded. Split: 0 buy · 1 sell. Total volume traded: €230k. History available since 5 May 2021. The latest transaction was disclosed on 27 April 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Winters Chad
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations17 total
896 shares@ US$173.220.0006% mcap12.6% of flowCommon StockSEC:0000105770-26-000053:0
896 shares@ US$300.66880.0010% mcap21.9% of flowCommon StockSEC:0000105770-26-000053:1
89.328 sharesCommon StockSEC:0000105770-26-000023:0
149.684 shares0Common StockSEC:0000105770-26-000018:0
82.054 shares@ US$211.002.4% of flowCommon StockSEC:0001127602-25-006118:0
675 shares@ US$173.2215.6% of flowCommon StockSEC:0001127602-24-009590:0
179 shares0Common StockSEC:0001127602-24-006414:0
456 shares@ US$143.438.8% of flowCommon StockSEC:0001127602-23-030255:0
456 shares@ US$143.438.8% of flowCommon StockSEC:0001127602-23-028965:0
872 shares@ US$143.4317.0% of flowCommon StockSEC:0001562180-23-004626:0
10 shares@ US$368.460.5% of flowCommon StockSEC:0001562180-23-004003:0
476 shares@ US$306.6819.9% of flowCommon StockSEC:0001562180-23-001798:0
47 shares@ US$225.511.6% of flowCommon StockSEC:0001562180-22-007398:0
10 shares@ US$314.760.0000% mcap1.7% of flowCommon StockSEC:0001562180-22-003850:0
414 shares@ US$369.130.0007% mcap77.0% of flowCommon StockSEC:0001562180-22-001859:0
47 shares@ US$429.881.7% of flowCommon StockSEC:0001562180-21-006716:0
10 shares@ US$328.600.3% of flowCommon StockSEC:0001562180-21-003318:0
About Winters Chad
Winters Chad is Directeur Financier and VP, Chief Accounting Officer at West Pharmaceutical Services INC, according to the companies listed. He has 17 filings in total, and across the 17 recent sampled filings the reported sell amount is EUR 229795, over the period from 2021-05-07 to 2026-04-29; the most frequent transaction nature is Levée d'options.